Alnylam Pharmaceuticals’ Approach For Transitioning From R&D To Commercial Mode

Three days before the 2015 Christmas holiday, Alnylam Pharmaceuticals and the Norton, MA, city council decided to exchange presents. The council signed off on a 13-year tax incentive (i.e., a $7 million tax break) in exchange for Alnylam agreeing to build a proposed $100 million facility that will eventually employ up to 220 workers. http://www.lifescienceleader.com/doc/alnylam-s-approach-for-transitioning-from-r-d-to-commercial-mode-0001